GLS (glutaminase) converts glutamine to glutamate; elevated GLS levels have been found in tumors and are functionally linked to several oncogenic transcription factors including Myc, NF-kB, c-Jun-induced cell growth in some cancers suggesting the potential of GLS as an important player in therapeutic strategy. The gene discussed is MYC; the disease is cancer.